151 related articles for article (PubMed ID: 17284529)
21. Presentation clinical, haematological and immunophenotypic features of 1081 patients with GPI-deficient (paroxysmal nocturnal haemoglobinuria) cells detected by flow cytometry.
Richards SJ; Dickinson AJ; Cullen MJ; Griffin M; Munir T; McKinley C; Mitchell LD; Newton DJ; Arnold L; Hill A; Hillmen P
Br J Haematol; 2020 Jun; 189(5):954-966. PubMed ID: 32103498
[TBL] [Abstract][Full Text] [Related]
22. Impaired glycosylation of glycosylphosphatidylinositol-anchor synthesis in paroxysmal nocturnal hemoglobinuria leucocytes.
Hidaka M; Nagakura S; Horikawa K; Kawaguchi T; Iwamoto N; Kagimoto T; Takatsuki K; Nakakuma H
Biochem Biophys Res Commun; 1993 Mar; 191(2):571-9. PubMed ID: 8461014
[TBL] [Abstract][Full Text] [Related]
23. Glycosyl phosphatidylinositol (GPI)-anchored molecules and the pathogenesis of paroxysmal nocturnal hemoglobinuria.
Boccuni P; Del Vecchio L; Di Noto R; Rotoli B
Crit Rev Oncol Hematol; 2000 Jan; 33(1):25-43. PubMed ID: 10714960
[TBL] [Abstract][Full Text] [Related]
24. Analysis of T cells in paroxysmal nocturnal hemoglobinuria provides direct evidence that thymic T-cell production declines with age.
Richards SJ; Morgan GJ; Hillmen P
Blood; 1999 Oct; 94(8):2790-9. PubMed ID: 10515882
[TBL] [Abstract][Full Text] [Related]
25. Clonal Cell Proliferation in Paroxysmal Nocturnal Hemoglobinuria: Evaluation of
Park J; Kim M; Kim Y; Han K; Chung NG; Cho B; Lee SE; Lee JW
Ann Lab Med; 2019 Sep; 39(5):438-446. PubMed ID: 31037862
[TBL] [Abstract][Full Text] [Related]
26. Paroxysmal nocturnal hemoglobinuria: the price for a chance.
Bessler M
Schweiz Med Wochenschr; 1996 Nov; 126(45):1912-21. PubMed ID: 8946596
[TBL] [Abstract][Full Text] [Related]
27. Clinical paroxysmal nocturnal hemoglobinuria is the result of expansion of glycosyl-phosphatidyl-inositol-anchored protein-deficient clone in the condition of deficient hematopoiesis.
Pakdeesuwan K; Muangsup W; Pratya YU; Issaragrisil S; Wanachiwanawin W
Int J Hematol; 2001 Jan; 73(1):64-70. PubMed ID: 11372757
[TBL] [Abstract][Full Text] [Related]
28. [Quantity and function of T cell subsets in patients with paroxysmal nocturnal hemoglobinuria].
Zhang T; Liang Y; Fu R; Li LJ; Wang J; Liu H; Wang HL; Ruan EB; Qu W; Wang GJ; Wu YH; Liu H; Wang HQ; Wang XM; Song J; Guan J; Xing LM; Shao ZH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):721-5. PubMed ID: 20561437
[TBL] [Abstract][Full Text] [Related]
29. Preferential expression of human Fc gamma RIIIPMN (CD16) in paroxysmal nocturnal hemoglobinuria. Discordant expression of glycosyl phosphatidylinositol-linked proteins.
Edberg JC; Salmon JE; Whitlow M; Kimberly RP
J Clin Invest; 1991 Jan; 87(1):58-67. PubMed ID: 1702101
[TBL] [Abstract][Full Text] [Related]
30. Regulation of glycoinositol phospholipid anchor assembly in human lymphocytes. Absent mannolipid synthesis in affected T and natural killer cell lines from paroxysmal nocturnal hemoglobinuria patients.
Schubert J; Schmidt RE; Medof ME
J Biol Chem; 1993 Mar; 268(9):6281-7. PubMed ID: 8454600
[TBL] [Abstract][Full Text] [Related]
31. A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia.
Wanachiwanawin W; Siripanyaphinyo U; Piyawattanasakul N; Kinoshita T
Eur J Haematol; 2006 Jun; 76(6):502-9. PubMed ID: 16529603
[TBL] [Abstract][Full Text] [Related]
32. Immunophenotypic analysis of B cells in PNH: insights into the generation of circulating naive and memory B cells.
Richards SJ; Morgan GJ; Hillmen P
Blood; 2000 Nov; 96(10):3522-8. PubMed ID: 11071650
[TBL] [Abstract][Full Text] [Related]
33. Deficiency of glycosyl phosphatidylinositol-anchored proteins in polymorphonuclear leukocytes from patients with paroxysmal nocturnal hemoglobinuria with low-grade hemolysis.
Shibuya K; Ninomiya H; Muraki Y; Nagasawa T; Abe T
Int J Hematol; 1993 Aug; 58(1-2):15-20. PubMed ID: 7693026
[TBL] [Abstract][Full Text] [Related]
34. GPI-defective monocytes from paroxysmal nocturnal hemoglobinuria patients show impaired in vitro dendritic cell differentiation.
Ruggiero G; Terrazzano G; Becchimanzi C; Sica M; Andretta C; Masci AM; Racioppi L; Rotoli B; Zappacosta S; Alfinito F
J Leukoc Biol; 2004 Sep; 76(3):634-40. PubMed ID: 15197238
[TBL] [Abstract][Full Text] [Related]
35. Flow cytometric analysis of glycosylphosphatidyl-inositol-anchored proteins to assess paroxysmal nocturnal hemoglobinuria clone size.
Piedras J; López-Karpovitch X
Cytometry; 2000 Aug; 42(4):234-8. PubMed ID: 10934342
[TBL] [Abstract][Full Text] [Related]
36. Detailed immunophenotypic characterization of different major and minor subsets of peripheral blood cells in patients with paroxysmal nocturnal hemoglobinuria.
Hernández-Campo PM; Almeida J; Acevedo MJ; Sánchez ML; Alberca I; Vidriales B; Martínez E; Romero JR; Orfao A
Transfusion; 2008 Jul; 48(7):1403-14. PubMed ID: 18422849
[TBL] [Abstract][Full Text] [Related]
37. Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes.
Dunn DE; Tanawattanacharoen P; Boccuni P; Nagakura S; Green SW; Kirby MR; Kumar MS; Rosenfeld S; Young NS
Ann Intern Med; 1999 Sep; 131(6):401-8. PubMed ID: 10498555
[TBL] [Abstract][Full Text] [Related]
38. Immunoselection by natural killer cells of PIGA mutant cells missing stress-inducible ULBP.
Hanaoka N; Kawaguchi T; Horikawa K; Nagakura S; Mitsuya H; Nakakuma H
Blood; 2006 Feb; 107(3):1184-91. PubMed ID: 16195329
[TBL] [Abstract][Full Text] [Related]
39. PNH cells are as sensitive to T-cell-mediated lysis as their normal counterparts: implications for the pathogenesis of paroxysmal nocturnal haemoglobinuria.
Karadimitris A; Notaro R; Koehne G; Roberts IA; Luzzatto L
Br J Haematol; 2000 Dec; 111(4):1158-63. PubMed ID: 11167756
[TBL] [Abstract][Full Text] [Related]
40. Glycosylphosphatidylinositol (GPI)-anchored surface antigens in the allogeneic activation of T cells.
Schubert J; Stroehmann A; Scholz C; Schmidt RE
Clin Exp Immunol; 1995 Oct; 102(1):199-203. PubMed ID: 7554390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
